STOCK TITAN

MediXall Group (MDXL) Stock Price, News & Analysis

MDXL OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
2 7 sessions, March 5, 2026 to November 4, 2026
Largest daily move
+2700% close of April 7, 2026

Company Description

MediXall Group (OTC: MDXL) is classified in the health information services industry within the Healthcare sector and carries a market capitalization of $678.2K.

For FY2023, MediXall Group reported revenue of $309K with net income of -$4.6M and diluted earnings per share of -$0.04.

This page collects what Stock Titan holds for MDXL, including price data, latest news, SEC filings, and financial highlights.

Stock Performance

$0.0033
No recent trading
Last close: November 4, 2026
-
1 year to November 4, 2026
$678.2K
205.5M
Shares outstanding As of September 2, 2025.

MediXall Group (MDXL) closed at $0.0033 on November 4, 2026.

See what a $1,000 investment in MDXL was worth at its last close

MDXL Metrics & Rankings

Market Cap
$678.2K
View ranking

Price returns through November 4, 2026. Ranking links may use different dates.

Latest News

MediXall Group has 10 recent news articles. Key topics include partnership, AI, conferences. View all MDXL news →

SEC Filings

MediXall Group has filed 4 recent SEC filings, including 3 Form NT 10-Q, 1 Form NT 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MDXL SEC filings →

Financial Highlights

MediXall Group generated $309K in revenue in FY2023, retaining a 23.6% gross margin, and net income was -$4.6M. Diluted earnings per share stood at -$0.04. The company generated -$1.2M in operating cash flow. The current ratio was 0.00, measuring current assets divided by current liabilities.

$309K
Revenue (FY2023)
-$4.6M
Net Income (FY2023)
-$1.2M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for MDXL.

MDXL Company Profile & Sector Positioning

MediXall Group (MDXL) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing MDXL often look at related companies in the same sector, including Cardiocom Sltns Inc (EKGGF), Dogecoin Cash Inc (DOGP), Nano Mobile Healthcare (VNTH), PPJ Healthcare Enterprise (PPJE), and EcoPlus Inc (ECPL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MDXL's relative position within its industry.

Frequently Asked Questions

MediXall Group (MDXL) has no recent trading. Its last close was $0.0033 on November 4, 2026.

The market cap of MediXall Group (MDXL) is approximately $678.2K. Learn more about what market capitalization means .

The FY2023 revenue of MediXall Group (MDXL) is $309K, from its most recent completed fiscal year.

The FY2023 net income of MediXall Group (MDXL) is -$4.6M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of MediXall Group (MDXL) is -$0.04 for FY2023, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of MediXall Group (MDXL) is -$1.2M for FY2023, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of MediXall Group (MDXL) is 23.6% for FY2023, its most recent completed fiscal year. Learn about gross margins.

The current ratio of MediXall Group (MDXL), current assets divided by current liabilities, was 0.00 at the end of FY2023, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of MediXall Group (MDXL) is $73K for FY2023, its most recent completed fiscal year.